Slide 1: 9M 2022 Update
9M 2022 Update November 2022 Innovation through formulation
Slide 2: Agenda
Agenda 1• Key developments & business update 2• Financial performance 3• Outlook 4• Q&A 2 © 2022 Azelis group. All rights reserved
Slide 3: Disclaimer
Disclaimer This document may contain statement relevant to Azelis Group NV (the “Company”) and/or its affiliated companies (collectively “Azelis” or the “Azelis Group”) which are not historical facts and are hereby identified as “forward-looking statements”. Such forward looking statements, include,
Slide 4: Key developments & business update 9M 2022
Key developments & business update 9M 2022 4 © 2022 Azelis group. All rights reserved
Slide 5: Key developments 9M 2022
Key developments 9M 2022 Sustained momentum Resilient margins Progress on initiatives Balance Sheet • 52.5% total revenue • 57.6% increase in • Continued investments • 81.4% increase in Free growth gross profit in digital strategy Cash Flow (€ 275.1m) despite elevated WC • 25.8% organic growth • 79.
Slide 6: Business update: Robust performance YTD
Business update: Robust performance YTD Organic growth: 25.8% in 9M 2022 • Life Sciences: Strong demand in Agri & Environmental Services in Q3; sustained momentum in Food & Nutrition and Personal Care • Industrial Chemicals: Continued pricing tailwinds support growth M&A: 8 acquisitions in 9M 2022 •
Slide 7: Financial performance 9M 2022
Financial performance 9M 2022 7 © 2022 Azelis group. All rights reserved
Slide 8: Headline P&L 9M 2022
Headline P&L 9M 2022 Azelis Group Highlights Reported Reported Constant Q3 2022 Q3 2021 9M 2022 9M 2021 (EUR m) Change Change Currency Life Sciences 652.1 457.6 42.5% 1860.8 1260.3 47.6% 42.7% Industrial Chemicals 436.6 270.7 61.3% 1247 777.4 60.4% 54.1% Group Revenue 1088.7 728.2 49.5% 3107.7 2037.
Slide 9: Headline growth 9M 2022
Headline growth 9M 2022 Azelis Performance F/X M&A Growth Organic Total 9M 2022 9M 2021 (EUR m) Translation Contribution Growth Growth EMEA 1371.0 894.3 -0.9% 21.9% 32.3% 53.3% Americas 1198.9 855.5 11.8% 11.0% 17.3% 40.1% Asia Pacific 537.8 286.4 6.8% 49.9% 31.1% 87.8% Group Revenue 3107.7 2037.7 5
Slide 10: Regional financial update
Regional financial update EMEA Americas Asia Pacific EBITA EBITA EBITA 10.6% 12.5% 11.8% 14.1% 7.5% 8.0% margin margin margin +53.3% € 1.371 +40.1% € 1.199 € 894 € 856 +87.8% € 538 Revenue Revenue Revenue € 286 Q3 2021 YTD Q3 2022 YTD Q3 2021 YTD Q3 2022 YTD Q3 2021 YTD Q3 2022 YTD 51,7% 56,0% Conve
Slide 11: Working Capital
Working Capital Working Capital Evolution of NWC* Receivables Inventory Payables NWC/ 9.2% 10.9% 11.1% 15.3% 13.6% 15.9% Revenue 653 467 391 256 262 268 531 376 367 167 200 218 -247 -227 -235 -355 -369 -494 2018 2019 2020 2021 9M 2021 9M 2022 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec DSO 32 34
Slide 12: Outlook
Outlook 12 © 2022 Azelis group. All rights reserved
Slide 13: Outlook
Outlook Our strategy of driving growth is underpinned by a constantly strengthening lateral value chain, supported by continuous investments in innovation capabilities and digitalization, as well as a commitment to sustainability to create long-term value. In line with this, we are positive that we
Slide 14: 9M 2022 Update Q&A
9M 2022 Update Q&A Contact Investor Relations investor-relations@azelis.com +32 (0) 478 51 23 89 14 © 2022 Azelis group. All rights reserved